Clinical trial
Donepezil for Residual Symptoms in CPAP Treated Obstructive Sleepapnea Patients: A Controlled Study
NCT03299257 is registered in ClinicalTrials.gov with Associação Fundo de Incentivo à Pesquisa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Donepezil for Residual Symptoms in CPAP Treated Obstructive Sleepapnea Patients: A Controlled Study
- Lead sponsor
- Associação Fundo de Incentivo à Pesquisa
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 6, 2018
- Completion date
- March 2, 2019
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osa, sleepiness